Medical And Surgical CEU Courses

This course will introduce clinicians to the latest in bone anchored hearing device clinical research. Clinical evidence for best practices will be discussed in this hour-long course.

Vestibular dysfunction and significant fall risks are more prevalent in the diabetic population. Learn about the pathophysiology and epidemiology of diabetes to improve your understanding of the impact this disease can have on balance function.

This webinar provides information on the theoretical foundation of current clinical and scientific approaches to the detection and management of ototoxicity. Limitations to this current theoretical framework are presented, along with new conceptions and approaches in the field of ototoxicity.

Menière Disease (MD) and Vestibular Migraine (VM) are the 2 most common causes of episodic vertigo. Diagnosis of both disorders is based on clinical history and on audiometric exam showing, in Menière Disease, sensorineural low-frequency hearing loss. At onset, differential diagnosis is often a puzzling dilemma, considering that around 50% of MD subjects also experience migraine, and VM patients, in many cases, report cochlear symptoms during attacks. Recent works propose that according to phenotypes and comorbidities, MD could be differentiated into subgroups, each presenting peculiarities for onset and evolution, MD with migraine among them. Other authors proposed a similar work for VM patients. In this webinar, Dr. R. Teggi examines clinical and etiological conditions commonly shared.

This course will discuss surgical aspects of The Ponto Implant system including details on Osseointegration, Minimally Invasive Ponto Surgery (MIPS), and MONO surgery, providing valuable information to any clinician recommending Bone Conduction amplification.

The participant in this course will understand the extended candidacy criteria with cochlear implantation and expectations. The course will cover implanting under age one, hybrid hearing with cochlear implantation, CI under local anesthesia, single-sided deafness, cochlear implantation, and auditory brainstem implantation.

Chronic Otitis Media (COM) may contribute more than half of the global burden of hearing loss, but there is no global consensus on diagnostic and treatment guidelines for hearing loss due to the disease. Research suggests that bone conduction may be an effective and patient-preferred alternative to treating COM-related hearing loss versus hearing aids for many patients, providing consistent and reliable access to sound regardless of the disease cycle. Topics in this course will include background on the disease process, an introduction to bone conduction solutions, and expected outcomes of the intervention.

Besides typical symptoms and signs (including pulsatile tinnitus, hyperacusis, pressure/sound-induced torsional nystagmus, conductive hearing loss and lowered thresholds of air-conducted VEMPs) an analysis of the relevant literature reveals a certain clinical polymorphism induced by superior canal dehiscence (SCD). In addition to asymptomatic persons or subjects with SCD presenting exclusively with cochlear symptoms (only partly explained by the so-called “near-dehiscence syndrome”), SCD cases mainly presenting with atypical/refractory/recurrent positional vertigo and/or Meniere-like vertigo spells have been recently described. Moreover, if surgical occlusion of the superior canal (SC) results in symptoms control inducing a selective SC hypofunction, clinicians my sometimes accidentally detect a reduced SC VOR gain in asymptomatic patients with wide-sized dehiscence. These findings led authors to propose the occurrence either of a natural SC plugging (complete or incomplete) by middle fossa dura prolapsing into the canal lumen or a dispersion of mechanical energy through the dehiscence. Typical and atypical scenarios is presented. A subsample of patients from the personal series with a complete otoneurologic assessment (audiometry, VOG eye recording, air/bone-conducted cervical/ocular VEMPs, video head impulse test) is selected to explain these emerging theories on possible pathomechanisms.

Experienced providers from Michigan Medicine will detail the patient journey from identification through intervention for vestibular schwannomas. This series will provide an overview of diagnostic auditory and vestibular evaluations relevant to vestibular schwannomas, medical and surgical management of these tumors from the perspective of a neurotologist, as well as intraoperative monitoring considerations.

This course will provide an overview of the techniques used to monitor hearing and facial nerve during vestibular schwannoma surgeries. Particular attention will be paid to monitoring and outcomes for hearing preservation surgeries.